Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Selective Dose Escalation of Chemoradiotherapy for Esophageal Cancer
NCT00139633Phase 2Unknown
- Sponsor
- The Oregon Clinic
- Start
- Jul 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, fluorouracil, paclitaxel in esophageal cancer, sponsored by The Oregon Clinic. Status: unknown.
02
Drugs
carboplatinfluorouracilpaclitaxel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00139633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139633.